India, July 21 -- ZimVie (ZIMV) announced a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED, an investment firm focused on healthcare industries. ZimVie stockholders will receive $19.00 in cash for each share of ZimVie common stock outstanding at the closing of the transaction, corresponding to an enterprise value of approximately $730 million. ZimVie, with the assistance of Centerview Partners, may solicit proposals from third parties for a period of 40 days.
ZimVie will become a privately held company and ZimVies shares will no longer be listed on the NASDAQ stock exchange.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Published by HT D...